Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
PHASE2
This phase II trial studies autologous peripheral blood stem cell transplan...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)
PHASE2
To evaluate toxicity profile and efficacy of a tandem autologous-nonmyeloab...
Status
Unknown
Location
Università di Torino - Azienda Ospedaliera S.Giovanni Battista
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
PHASE2
This phase II trial studies the side-effects and anti-cancer effects of giv...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium